Increased placental XIAP and caspase 3 is associated with increased placental apoptosis in a baboon model of maternal nutrient reduction

American Journal of Obstetrics and Gynecology

Volumn 203, Issue 4, 2010, Pages 364.e13-364.e18

  Arroyo, Juan A ^a   Li, Cun ^b   Schlabritz Loutsevitch, Natalia ^b   McDonald, Tom ^b   Nathanielsz, Peter ^b   Galan, Henry L ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

apoptosis; caspase 3; MNR; placenta; XIAP

Indexed keywords

CASPASE 3; CYTOKERATIN 18; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 10; PROTEIN KINASE B; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPSY; BABOON; CONTROLLED STUDY; DIET; FEMALE; FROZEN SECTION; IMMUNOHISTOCHEMISTRY; MATERNAL DISEASE; MATERNAL NUTRIENT REDUCTION; MATERNAL NUTRITION; NICK END LABELING; NONHUMAN; PLACENTA; PLACENTA WEIGHT; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; TISSUE FIXATION; ANIMAL; CHORION VILLUS; METABOLISM; NUTRITIONAL STATUS; ORGAN SIZE; PATHOLOGY;

ANIMALS; APOPTOSIS; CASPASE 3; CHORIONIC VILLI; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; IMMUNOHISTOCHEMISTRY; KERATIN-18; MODELS, ANIMAL; NUTRITIONAL STATUS; ORGAN SIZE; PAPIO; PLACENTA; PREGNANCY; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 77957360215     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.05.021     Document Type: Article

References (31)

1. N. Schlabritz-Loutsevitch, B. Ballesteros, and C. Dudley Moderate maternal nutrient restriction, but not glucocorticoid administration, leads to placental morphological changes in the baboon (Papio sp) Placenta 28 2007 783 793
2. S.W. Hetts To die or not to die: an overview of apoptosis and its role in disease JAMA 279 1998 300 307
3. T.H. Hung, J.N. Skepper, D.S. Charnock-Jones, and G.J. Burton Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia Circ Res 90 2002 1274 1281
4. B. Huppertz, H.G. Frank, F. Reister, J. Kingdom, H. Korr, and P. Kaufmann Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro Lab Invest 79 1999 1687 1702
5. D.N. Leung, S.C. Smith, K.F. To, D.S. Sahota, and P.N. Baker Increased placental apoptosis in pregnancies complicated by preeclampsia Am J Obstet Gynecol 184 2001 1249 1250
6. R. Levy, and D.M. Nelson To be, or not to be, that is the question: apoptosis in human trophoblast Placenta 21 2000 1 13
7. V.S. Ratts, X.J. Tao, and C.B. Webster Expression of BCL-2, BAX and BAK in the trophoblast layer of the term human placenta: a unique model of apoptosis within a syncytium Placenta 21 2000 361 366
8. Y. Suzuki, Y. Nakabayashi, K. Nakata, J.C. Reed, and R. Takahashi X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes J Biol Chem 276 2001 27058 27063
9. E.M. Creagh, and S.J. Martin Caspases: cellular demolition experts Biochem Soc Trans 29 2001 696 702
10. M. Kadyrov, P. Kaufmann, and B. Huppertz Expression of a cytokeratin 18 neo-epitope is a specific marker for trophoblast apoptosis in human placenta Placenta 22 2001 44 48
11. A. Gruslin, Q. Qiu, and B.K. Tsang X-linked inhibitor of apoptosis protein expression and the regulation of apoptosis during human placental development Biol Reprod 64 2001 1264 1272
12. J.A. Arroyo, R.V. Anthony, and H.L. Galan Decreased placental X-linked inhibitor of apoptosis protein in an ovine model of intrauterine growth restriction Am J Obstet Gynecol 199 2008 80 88
13. T.G. Cross, D. Scheel-Toellner, N.V. Henriquez, E. Deacon, M. Salmon, and J.M. Lord Serine/threonine protein kinases and apoptosis Exp Cell Res 256 2000 34 41
14. R.J. Davis Signal transduction by the JNK group of MAP kinases Cell 103 2000 239 252
15. R. Ain, L.N. Canham, and M.J. Soares Dexamethasone-induced intrauterine growth restriction impacts the placental prolactin family, insulin-like growth factor-II and the Akt signaling pathway J Endocrinol 185 2005 253 263
16. P.A. Gruppuso, J.M. Boylan, P. Anand, and T.C. Bienieki Effects of maternal starvation on hepatocyte proliferation in the late gestation fetal rat Pediatr Res 57 2005 185 191
17. R.G. Lea, P. Wooding, and I. Stewart The expression of ovine placental lactogen, StAR and progesterone-associated steroidogenic enzymes in placentae of overnourished growing adolescent ewes Reproduction 133 2007 785 796
18. T.J. McDonald, M.J. Nijland, and P.W. Nathanielsz The insulin-like growth factor system and the fetal brain: effects of poor maternal nutrition Rev Endocr Metab Disord 8 2007 71 84
19. W.J. Murdoch, E.A. Van Kirk, K.A. Vonnahme, and S.P. Ford Ovarian responses to undernutrition in pregnant ewes, USA Reprod Biol Endocrinol 1 2003 6
20. N.E. Schlabritz-Loutsevitch, C.J. Dudley, and J.J. Gomez Metabolic adjustments to moderate maternal nutrient restriction Br J Nutr 98 2007 276 284
21. S.C. Smith, P.N. Baker, and E.M. Symonds Increased placental apoptosis in intrauterine growth restriction Am J Obstet Gynecol 177 1997 1395 1401
22. S.C. Smith, E. Price, M.J. Hewitt, E.M. Symonds, and P.N. Baker Cellular proliferation in the placenta in normal human pregnancy and pregnancy complicated by intrauterine growth restriction J Soc Gynecol Investig 5 1998 317 323
23. A.D. Allaire, K.A. Ballenger, S.R. Wells, M.J. McMahon, and B.A. Lessey Placental apoptosis in preeclampsia Obstet Gynecol 96 2000 271 276
24. N. Ishihara, H. Matsuo, H. Murakoshi, J.B. Laoag-Fernandez, T. Samoto, and T. Maruo Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation Am J Obstet Gynecol 186 2002 158 166
25. T. Ozaki, H. Nishina, M.A. Hanson, and L. Poston Dietary restriction in pregnant rats causes gender-related hypertension and vascular dysfunction in offspring J Physiol 530 2001 141 152
26. J.A. Armitage, I.Y. Khan, P.D. Taylor, P.W. Nathanielsz, and L. Poston Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals? J Physiol 561 suppl 2004 355 377
27. L. Heasman, L. Clarke, T.J. Stephenson, and M.E. Symonds The influence of maternal nutrient restriction in early to mid-pregnancy on placental and fetal development in sheep Proc Nutr Soc 58 1999 283 288
28. D.J. Barker Adult consequences of fetal growth restriction Clin Obstet Gynecol 49 2006 270 283
29. L.A. Cox, M.J. Nijland, and J.S. Gilbert Effect of 30 per cent maternal nutrient restriction from 0.16 to 0.5 gestation on fetal baboon kidney gene expression J Physiol 572 2006 67 85
30. C. Li, N.E. Schlabritz-Loutsevitch, and G.B. Hubbard Effects of maternal global nutrient restriction on fetal baboon hepatic insulin-like growth factor system genes and gene products Endocrinology 150 2009 4634 4642
31. N. Ishihara, H. Matsuo, H. Murakoshi, J.B. Laoag-Fernandez, T. Samoto, and T. Maruo Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation Am J Obstet Gynecol 186 2002 158 166